These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 10433091)
1. Immune reactivity following CD40L blockade: role in autoimmune glomerulonephritis in susceptible recipients. Banu N; Zhang Y; Meyers CM Autoimmunity; 1999; 30(1):21-33. PubMed ID: 10433091 [TBL] [Abstract][Full Text] [Related]
2. Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels. Maeda T; Nomoto K J Rheumatol; 1995 Dec; 22(12):2259-65. PubMed ID: 8835559 [TBL] [Abstract][Full Text] [Related]
3. Breaking of CD8+ T cell tolerance through in vivo ligation of CD40 results in inhibition of chronic graft-versus-host disease and complete donor cell engraftment. Kim J; Park K; Kim HJ; Kim J; Kim HA; Jung D; Kim HJ; Choi HJ; Choi SY; Seo KW; Cho HR; Kwon B J Immunol; 2008 Nov; 181(10):7380-9. PubMed ID: 18981161 [TBL] [Abstract][Full Text] [Related]
4. Characterization of reactivity of monoclonal autoantibodies with renal antigens in experimental lupus nephritis. Kootstra JC; Veninga A; Baelde JJ; van Eendenburg J; de Heer E; Bruijn JA J Clin Lab Immunol; 1996; 48(5):201-18. PubMed ID: 9394243 [TBL] [Abstract][Full Text] [Related]
5. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172 [TBL] [Abstract][Full Text] [Related]
6. Effective treatment of experimental lupus nephritis by combined administration of anti-CD11a and anti-CD54 antibodies. Kootstra CJ; Van Der Giezen DM; Van Krieken JH; De Heer E; Bruijn JA Clin Exp Immunol; 1997 May; 108(2):324-32. PubMed ID: 9158106 [TBL] [Abstract][Full Text] [Related]
7. Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease. Kairaitis L; Wang Y; Zheng L; Tay YC; Wang Y; Harris DC Kidney Int; 2003 Oct; 64(4):1265-72. PubMed ID: 12969144 [TBL] [Abstract][Full Text] [Related]
8. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424 [TBL] [Abstract][Full Text] [Related]
9. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872 [TBL] [Abstract][Full Text] [Related]
10. Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides. Yellin MJ; D'Agati V; Parkinson G; Han AS; Szema A; Baum D; Estes D; Szabolcs M; Chess L Arthritis Rheum; 1997 Jan; 40(1):124-34. PubMed ID: 9008608 [TBL] [Abstract][Full Text] [Related]
11. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade. Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092 [TBL] [Abstract][Full Text] [Related]
12. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis. Nishikawa K; Guo YJ; Miyasaka M; Tamatani T; Collins AB; Sy MS; McCluskey RT; Andres G J Exp Med; 1993 Mar; 177(3):667-77. PubMed ID: 8094735 [TBL] [Abstract][Full Text] [Related]
13. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice. Gao D; Li J; Orosz CG; Bumgardner GL Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the requirements for the induction of CD4+ T cell alloantigen hyporesponsiveness by ex vivo anti-CD40 ligand antibody. Taylor PA; Panoskaltsis-Mortari A; Noelle RJ; Blazar BR J Immunol; 2000 Jan; 164(2):612-22. PubMed ID: 10623802 [TBL] [Abstract][Full Text] [Related]
15. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand. Wu Y; Xu J; Shinde S; Grewal I; Henderson T; Flavell RA; Liu Y Curr Biol; 1995 Nov; 5(11):1303-11. PubMed ID: 8574588 [TBL] [Abstract][Full Text] [Related]
16. Experimental autoimmune anti-glomerular basement membrane glomerulonephritis: a protective role for IFN-gamma. Kitching AR; Turner AL; Semple T; Li M; Edgtton KL; Wilson GR; Timoshanko JR; Hudson BG; Holdsworth SR J Am Soc Nephrol; 2004 Jul; 15(7):1764-74. PubMed ID: 15213264 [TBL] [Abstract][Full Text] [Related]
17. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway. Ito H; Kurtz J; Shaffer J; Sykes M J Immunol; 2001 Mar; 166(5):2970-81. PubMed ID: 11207246 [TBL] [Abstract][Full Text] [Related]
18. Regulatory T Cell-Dependent and -Independent Mechanisms of Immune Suppression by CD28/B7 and CD40/CD40L Costimulation Blockade. Vogel I; Verbinnen B; Van Gool S; Ceuppens JL J Immunol; 2016 Jul; 197(2):533-40. PubMed ID: 27288533 [TBL] [Abstract][Full Text] [Related]
19. Histological characteristics of lupus nephritis in F1 mice with chronic graft-versus-host reaction across MHC class II difference. Ito S; Ueno M; Nishi S; Arakawa M; Ikarashi Y; Saitoh T; Fujiwara M Autoimmunity; 1992; 12(2):79-87. PubMed ID: 1617113 [TBL] [Abstract][Full Text] [Related]
20. IFN-gamma and LPS differentially modulate class II MHC and B7-1 expression on murine renal tubular epithelial cells. Banu N; Meyers CM Kidney Int; 1999 Jun; 55(6):2250-63. PubMed ID: 10354273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]